What does Dr. Sophie Janssens, Dermatologie do?

Dr. Sophie Janssens, Dermatologie is a specialist medical practice in Kortrijk. Private Limited, started on 6 February 2019, 1 establishment.

What is the address of Dr. Sophie Janssens, Dermatologie?

The registered office of Dr. Sophie Janssens, Dermatologie is located at Lindendreef(RoL) 12, 8510 Kortrijk.

Is Dr. Sophie Janssens, Dermatologie still active?

Yes. According to the CBE (18 September 2026) Dr. Sophie Janssens, Dermatologie is active, legal situation “Normale toestand”, started on 6 February 2019.

Is Dr. Sophie Janssens, Dermatologie registered on Peppol?

Yes, Dr. Sophie Janssens, Dermatologie is registered on the Peppol network with ID 0208:0719903217.

What is the enterprise number of Dr. Sophie Janssens, Dermatologie?

The enterprise number of Dr. Sophie Janssens, Dermatologie is BE0719903217.

When was Dr. Sophie Janssens, Dermatologie founded?

Dr. Sophie Janssens, Dermatologie was founded on 6 February 2019.

Who are the directors of Dr. Sophie Janssens, Dermatologie?

According to the 2025 annual accounts, the directors of Dr. Sophie Janssens, Dermatologie are: SOPHIE JANSSENS.

Is Dr. Sophie Janssens, Dermatologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 February 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Sophie Janssens, Dermatologie make in 2025?

Dr. Sophie Janssens, Dermatologie posted a profit after taxes of € 141,939 in financial year 2025.

What is the revenue of Dr. Sophie Janssens, Dermatologie?

As a small company, Dr. Sophie Janssens, Dermatologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 203,894.

Dr. Sophie Janssens, Dermatologie (Private Limited)

Dossier Dr. Sophie Janssens, Dermatologie, printed on 18 September 2026 from databakkes.be/en/0719903217/dr-sophie-janssens-dermatologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Sophie Janssens, Dermatologie from Kortrijk, company number BE0719903217, closed financial year 2025 with a result of € 141,939 after tax. For that financial year Dr. Sophie Janssens, Dermatologie recorded a gross margin of € 203,894 and equity of € 18,600. Compared with financial year 2024, the result moved from € 129,841 to € 141,939. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 16, 2026.

What it is worth Healthy

€ 18,600

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 141,939

▲ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 22,832

▼ 65% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 141,939 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,831

▼ 46% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 68,030

▼ 18% vs 2024

€ 15,195 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 1,933

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 66

▼ 57% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 110,810 Gross margin 2022: € 110,810 First fiscal year in the series	€ 137,386 Gross margin 2023: € 137,386 ▲ 24% vs 2022 (€ 110,810) Favourable step	€ 185,385 Gross margin 2024: € 185,385 ▲ 35% vs 2023 (€ 137,386) Favourable step	€ 203,894 Gross margin 2025: € 203,894 ▲ 10% vs 2024 (€ 185,385) Favourable step	▲ 10%
Profit after taxes	€ 73,762 Profit after taxes 2022: € 73,762 First fiscal year in the series	€ 91,002 Profit after taxes 2023: € 91,002 ▲ 23% vs 2022 (€ 73,762) Favourable step	€ 129,841 Profit after taxes 2024: € 129,841 ▲ 43% vs 2023 (€ 91,002) Favourable step	€ 141,939 Profit after taxes 2025: € 141,939 ▲ 9% vs 2024 (€ 129,841) Favourable step	▲ 9%
Equity	€ 91,562 Equity 2022: € 91,562 First fiscal year in the series	€ 108,769 Equity 2023: € 108,769 ▲ 19% vs 2022 (€ 91,562) Favourable step	€ 18,600 Equity 2024: € 18,600 ▼ 83% vs 2023 (€ 108,769) Unfavourable step	€ 18,600 Equity 2025: € 18,600 Unchanged (€ 18,600) Unchanged
Total debts	€ 220,663 Total debts 2022: € 220,663 First fiscal year in the series	€ 115,843 Total debts 2023: € 115,843 ▼ 48% vs 2022 (€ 220,663) Favourable step	€ 221,446 Total debts 2024: € 221,446 ▲ 91% vs 2023 (€ 115,843) Unfavourable step	€ 177,123 Total debts 2025: € 177,123 ▼ 20% vs 2024 (€ 221,446) Favourable step	▼ 20%
Cash	€ 39,469 Cash 2022: € 39,469 First fiscal year in the series	€ 30,893 Cash 2023: € 30,893 ▼ 22% vs 2022 (€ 39,469) Unfavourable step	€ 64,990 Cash 2024: € 64,990 ▲ 110% vs 2023 (€ 30,893) Favourable step	€ 22,832 Cash 2025: € 22,832 ▼ 65% vs 2024 (€ 64,990) Unfavourable step	▼ 65%
Retained profit	€ 72,962 Retained profit 2022: € 72,962 First fiscal year in the series	€ 90,169 Retained profit 2023: € 90,169 ▲ 24% vs 2022 (€ 72,962) Favourable step	€ 0 Retained profit 2024: € 0 ▼ 100% vs 2023 (€ 90,169) Unfavourable step	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 110,956 Dividend 2022: € 110,956 First fiscal year in the series	€ 73,795 Dividend 2023: € 73,795 ▼ 33% vs 2022 (€ 110,956) Unchanged	€ 220,010 Dividend 2024: € 220,010 ▲ 198% vs 2023 (€ 73,795) Unchanged	€ 141,939 Dividend 2025: € 141,939 ▼ 35% vs 2024 (€ 220,010) Unchanged	▼ 35%
Bank debt	€ 112,506 Bank debt 2022: € 112,506 First fiscal year in the series	€ 97,862 Bank debt 2023: € 97,862 ▼ 13% vs 2022 (€ 112,506) Favourable step	€ 83,039 Bank debt 2024: € 83,039 ▼ 15% vs 2023 (€ 97,862) Favourable step	€ 68,030 Bank debt 2025: € 68,030 ▼ 18% vs 2024 (€ 83,039) Favourable step	▼ 18%
Balance sheet total	€ 312,225 Balance sheet total 2022: € 312,225 First fiscal year in the series	€ 224,612 Balance sheet total 2023: € 224,612 ▼ 28% vs 2022 (€ 312,225) Unchanged	€ 240,046 Balance sheet total 2024: € 240,046 ▲ 7% vs 2023 (€ 224,612) Unchanged	€ 195,723 Balance sheet total 2025: € 195,723 ▼ 18% vs 2024 (€ 240,046) Unchanged	▼ 18%

Key figures of Dr. Sophie Janssens, Dermatologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Sophie Janssens, Dermatologie?

What happened at Dr. Sophie Janssens, Dermatologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 16, 2026 New annual accounts for financial year 2025: profit of € 141,939 (▲ 9% vs 2024). Source: NBB ↗
Jul 1, 2019 New establishment in Kortrijk. KBO
Feb 6, 2019 Start of the company according to the CBE. KBO

In short

From € 73,762 profit in 2022 to € 141,939 profit in 2025.

Paid € 122,541 in corporate taxes since 2022.

Best year ever: 2025, with € 141,939 profit.

Paid out € 546,700 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Sophie Janssens, Dermatologie? We notify you, reason included.

Follow Dr. Sophie Janssens, Dermatologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

SOPHIE JANSSENS

Dr. Sophie Janssens, Dermatologie

Behind Dr. Sophie Janssens, Dermatologie is SOPHIE JANSSENS.

See the full network in the app

Directors

According to the 2025 annual accounts

SOPHIE JANSSENS

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Lindendreef(RoL) 12

8510 Kortrijk

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

DR. LUDOVIC D'HULST

€ 425,941 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0719.903.217

VAT number

BE 0719.903.217

Registered office

Lindendreef(RoL) 12, 8510 Kortrijk

Names & denominations

Dr. Sophie Janssens, Dermatologie

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

6 February 2019

Peppol

Active · Active since 1 Apr 2026

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Sophie Janssens, Dermatologie

Financials

What happened to Dr. Sophie Janssens, Dermatologie?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions